Untreated symptomatic brain or leptomeningeal metastatic disease. 
Medical or psychiatric conditions comprising informed consent. 
Any medical condition which in the opinion of the investigator would compromise the ability of the patient to participate in the trial or which would jeopardise compliance with the protocol. 
Radiotherapy within 4 weeks of trial entry. 
Active autoimmune disease that has required systemic treatment in past 2 years 
Chronic usage of steroids or other immunosuppressant medication. 
Previous history of pneumonitis. 
Any evidence of clinical autoimmunity.       
    
